Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Leukemia (5)
Blood Cancer Journal (4)
Nature Communications (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (6)
Reviews (3)
Correspondence (1)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Cell biology
Diseases
Drug discovery
Genetics
Health care
Oncology
Pathogenesis

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–10 of 10 results

Advanced filters: Author: C. Pawlyn Clear advanced filters

APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma

Rearrangements of the Ig loci are essential for generating antibody diversity but abnormal translocations can be a driving event for myeloma. Here Walker et al. perform whole exome sequencing on myeloma patients to capture the diversity of mutational changes.

Brian A. Walker
Christopher P. Wardell
Gareth J. Morgan
Research23 Apr 2015
Nature Communications

Volume: 6, P: 1-11
Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network

H Ludwig
M Delforge
P Sonneveld
ReviewsOpen Access18 Dec 2017
Leukemia

P: 1-46
Mutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugs

J. R. Jones
A. Barber
C. Pawlyn
ResearchOpen Access09 Aug 2021
Leukemia

Volume: 35, P: 3017-3020
Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry

H. V. Giles
M. T. Drayson
G. H. Jackson
ResearchOpen Access18 Mar 2024
Blood Cancer Journal

Volume: 14, P: 1-10
Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control

C Pawlyn
M D Bright
F E Davies
ResearchOpen Access31 Mar 2017
Blood Cancer Journal

Volume: 7, P: e549
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm

Charlotte Pawlyn
Fredrik H. Schjesvold
Paul G. Richardson
ReviewsOpen Access12 Aug 2024
Blood Cancer Journal

Volume: 14, P: 1-8
Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?

C Pawlyn
L Fowkes
C Messiou
CorrespondenceOpen Access09 Dec 2015
Leukemia

Volume: 30, P: 1446-1448
Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial

J R Jones
D A Cairns
G J Morgan
ResearchOpen Access09 Dec 2016
Blood Cancer Journal

Volume: 6, P: e506
Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients

V Shah
A L Sherborne
M F Kaiser
ResearchOpen Access06 Jun 2017
Leukemia

Volume: 32, P: 102-110
Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network

Heinz Ludwig
Mario Boccadoro
Pieter Sonneveld
ReviewsOpen Access19 Aug 2020
Leukemia

Volume: 35, P: 31-44

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com footer links

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

Search

APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma

Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network

Mutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugs

Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control

Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm

Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?

Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial

Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients

Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network

Search

Quick links